业界动态国内医卫资讯
Naronapride在2期试验中缓解胃轻瘫症状
Medscape News · 2026-10-31 00:09
摘要
一项2期试验显示，研究性促动力药Naronapride在每日三次、每次20 mg和40 mg给药时，对胃轻瘫症状的改善程度大于安慰剂。Medscape Medical News
English
Naronapride Eases Gastroparesis Symptoms in Phase 2 Trial
Naronapride, an investigational prokinetic, leads to greater improvements in gastroparesis symptoms than placebo when administered at 20 and 40 mg three times daily, a phase 2 trial shows. Medscape Medical News